FindTrial
Sign In

Multicenter real-world study of zopiclone tablets in the treatment of insomnia

Multicenter real-world study of zopiclone tablets in the treatment of insomnia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092144
Enrollment
Unknown
Registered
2024-11-11
Start date
2024-01-31
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Case series (Zopiclone treatment group):none

Sponsors

Tianjin Anding Hospital ( Tianjin Mental Health Center )
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inpatients or outpatients ; meet the diagnostic criteria of ICD-10 insomnia ; age >= 18 years old, male or female ; combined with other psychiatric drugs is not limited.

Exclusion criteria

Exclusion criteria: Alcohol/drug dependence, pregnant or lactating women, patients with myasthenia gravis, patients with severe respiratory insufficiency, patients with severe apnea syndrome, patients with severe acute and chronic liver dysfunction.

Design outcomes

Secondary

MeasureTime frame
Morisky Medication Adherence Scale ;—

Primary

MeasureTime frame
the sleep quality assessment(PSQI);—

Countries

China

Contacts

Public ContactLi shen

Tianjin Anding Hospital

lishen@tmu.edu.cn+86 153 2006 0306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026